Analytical Data
-
基因名
VIT
- Application
-
别名
VIT; UNQ647/PRO1277; Vitrin
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q6UXI7
-
表达区间
27-678 aa
-
氨基酸序列
NKET AKKIKRPKFT VPQINCDVKA GKIIDPEFIV KCPAGCQDPK YHVYGTDVYA SYSSVCGAAV HSGVLDNSGG KILVRKVAGQ SGYKGSYSNG VQSLSLPRWR ESFIVLESKP KKGVTYPSAL TYSSSKSPAA QAGETTKAYQ RPPIPGTTAQ PVTLMQLLAV TVAVATPTTL PRPSPSAAST TSIPRPQSVG HRSQEMDLWS TATYTSSQNR PRADPGIQRQ DPSGAAFQKP VGADVSLGLV PKEELSTQSL EPVSLGDPNC KIDLSFLIDG STSIGKRRFR IQKQLLADVA QALDIGPAGP LMGVVQYGDN PATHFNLKTH TNSRDLKTAI EKITQRGGLS NVGRAISFVT KNFFSKANGN RSGAPNVVVV MVDGWPTDKV EEASRLARES GINIFFITIE GAAENEKQYV VEPNFANKAV CRTNGFYSLH VQSWFGLHKT LQPLVKRVCD TDRLACSKTC LNSADIGFVI DGSSSVGTGN FRTVLQFVTN LTKEFEISDT DTRIGAVQYT YEQRLEFGFD KYSSKPDILN AIKRVGYWSG GTSTGAAINF ALEQLFKKSK PNKRKLMILI TDGRSYDDVR IPAMAAHLKG VITYAIGVAW AAQEELEVIA THPARDHSFF VDEFDNLHQY VPRIIQNICT EFNSQPRN
-
分子量
73.9 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
VIT recombinant protein research has gained significant attention in the fields of biotechnology and medicine due to its potential applications in vaccine development, diagnostics, and therapeutic interventions. VIT, or Virus-Induced Tumor proteins, play a crucial role in understanding the mechanisms by which viral infections can lead to tumorigenesis. As recombinant DNA technology has advanced, scientists have been able to produce VIT proteins in host organisms such as bacteria, yeast, and mammalian cells, allowing for the detailed study of their structure, function, and interaction with host immune systems. This research is particularly relevant in the context of developing targeted cancer therapies and effective vaccines, as VIT proteins can serve as biomarkers or therapeutic targets. Furthermore, the ability to manipulate these proteins at the genetic level provides an opportunity to explore novel strategies for combating viral pathogens and understanding their association with cancer development. Overall, the exploration of VIT recombinant proteins is a promising frontier in biomedical research, aiming to enhance our understanding of viral oncogenesis and improve public health outcomes through innovative therapeutic and preventive measures.
